𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of drugs against hormone-refractory prostate cancer

✍ Scribed by Yukio Kageyama

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
223 KB
Volume
69
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroendocrine differentiation and hormo
Neuroendocrine differentiation and hormone-refractory prostate cancer
✍ Abrahamsson, Per-Anders πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 507 KB

There is an intriguing link between differentiation of neuroendocrine cells and tumor progression in prostate cancer. Neuroendocrine differentiation appears to be associated with the androgen-independent state, for which there is currently no successful therapy. However, the role of the neuroendocri

Androgen receptor gene mutations in horm
Androgen receptor gene mutations in hormone-refractory prostate cancer
✍ WallοΏ½n, Mika J.; Linja, Marika; Kaartinen, Kaius; Schleutker, Johanna; Visakorpi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 2 views

Prostate cancer is considered to be one of the most hormone-dependent human malignancies. As a key mediator of hormonal response, the androgen receptor (AR) is believed to have an important role in the progression of prostate cancer. Mutations in the coding region of the AR gene have been found in b